Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 150 of 506 entries
View as:

Pharmacodynamic Study to Compare Acute Effects of Dihydroergotamine Mesylate (DHE) on Pulmonary Arterial Pressure

Phase: N/A Priority: Normal
NCT ID: NCT01089062 Org: User:
Start: 03/31/10 End: 12/31/10 Due: 12/31/11

Retrospective Study of Reoperation After Primary Augmentation With NATRELLE® INSPIRA® Breast Implants

Phase: N/A Priority: Normal
NCT ID: NCT02438332 Org: User:
Start: 12/31/14 End: 06/30/16 Due: 06/30/17

Local Pharmacokinetics and Tolerability of Bimatoprost Applied to the Scalp of Male Patients With Androgenetic Alopecia

Phase: N/A Priority: Normal
NCT ID: NCT02848300 Org: User:
Start: 07/31/16 End: 10/31/16 Due: 10/31/17

AGN-151586 Dose-Ranging Study for Treatment of Glabellar Lines

Phase: N/A Priority: Normal
NCT ID: NCT04096326 Org: User:
Start: 09/26/19 End: 09/09/20 Due: 09/09/21

Internet-based, Naturalistic Evaluation of Tolerability and Individual Patient Target Pressures With Bimatoprost 0.03% in Glaucoma

Phase: N/A Priority: Normal
NCT ID: NCT00487214 Org: User:
Start: 06/30/02 End: 02/28/03 Due: 02/28/04

Safety and Efficacy of Two Artificial Tears in Dry Eye Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01010282 Org: User:
Start: 11/30/09 End: 04/30/10 Due: 04/30/11

A Study to Evaluate The Impact on Skin Quality Attributes by Juvederm® Volite Injection on Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT04206293 Org: User:
Start: 10/08/19 End: 07/29/20 Due: 07/29/21

A Study of Bimatoprost 0.01% in the Clinical Setting

Phase: N/A Priority: Normal
NCT ID: NCT01814761 Org: User:
Start: 05/31/13 End: 08/31/14 Due: 08/31/15

A Multicenter Prospective Non-Interventional Study Assessing the Management of Canadian Women With Uterine Fibroids

Phase: N/A Priority: Normal
NCT ID: NCT02580578 Org: User:
Start: 07/31/15 End: 01/31/20 Due: 01/31/21

An Efficacy and Safety Study of Bimatoprost 0.01% Alone Compared With Travoprost 0.004% and Timolol 0.5% in Subjects With Glaucoma or Ocular Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT01881126 Org: User:
Start: 06/30/13 End: 10/31/14 Due: 10/31/15

JUVÉDERM® VOLUMA® With Lidocaine for Correction of Temple Hollowing in Chinese Population

Phase: N/A Priority: Normal
NCT ID: NCT04891419 Org: User:
Start: 07/20/21 End: 11/22/23 Due: 11/22/24

A Safety and Efficacy Study of LiRIS® in Females With Interstitial Cystitis With Hunner's Lesions

Phase: N/A Priority: Normal
NCT ID: NCT02395042 Org: User:
Start: 04/15/15 End: 11/20/17 Due: 11/20/18

A Study of 2 Doses of MAP0010 in Adult Asthmatics

Phase: N/A Priority: Normal
NCT ID: NCT00554970 Org: User:
Start: 11/30/07 End: 03/31/08 Due: 03/31/09

A Study of OnabotulinumtoxinA X Injection in Adult Participants With Glabellar Lines

Phase: N/A Priority: Normal
NCT ID: NCT05013424 Org: User:
Start: 09/01/21 End: 07/07/22 Due: 07/07/23

Safety, Efficacy, Tolerability and Pharmacokinetics of AGN-223575 Ophthalmic Suspension in Patients With Dry Eye Disease

Phase: N/A Priority: Normal
NCT ID: NCT02435914 Org: User:
Start: 06/30/15 End: 01/31/16 Due: 01/31/17

NATRELLE® 410 Full and Moderate Height/Projection Breast Implant Continued Access Post-Approval Study

Phase: N/A Priority: Normal
NCT ID: NCT01853605 Org: User:
Start: 04/30/03 End: 08/31/14 Due: 08/31/15

A Phase 3 Efficacy Study of Pilocarpine HCl Ophthalmic Solution (AGN-190584) in Participants With Presbyopia

Phase: N/A Priority: Normal
NCT ID: NCT03857542 Org: User:
Start: 03/01/19 End: 09/10/20 Due: 09/10/21

Chart Review: Drug Utilization Study in Participants Who Received Ozurdex™ (Dexamethasone Intravitreal Implant) 0.7 mg Injections for Visual Impairment Due to Diabetic Macular Edema (DME)

Phase: N/A Priority: Normal
NCT ID: NCT03889444 Org: User:
Start: 01/15/19 End: 06/07/19 Due: 06/07/20

A Study of LUMIGAN® RC in the Clinical Setting

Phase: N/A Priority: Normal
NCT ID: NCT01833741 Org: User:
Start: 12/31/09 End: 03/31/11 Due: 03/31/12

Study to Evaluate Safety of Brimonidine/Timolol Fixed Combination in Glaucoma or Ocular Hypertension Patients

Phase: N/A Priority: Normal
NCT ID: NCT00651612 Org: User:
Start: 11/30/05 End: 01/31/07 Due: 01/31/08

A Study of the Safety and Efficacy of a New Treatment for Macular Edema Resulting From Retinal Vein Occlusion

Phase: N/A Priority: Normal
NCT ID: NCT00168324 Org: User:
Start: 10/01/04 End: 10/01/08 Due: 10/01/09

A Study of the Safety and Efficacy of a New Treatment for Diabetic Macular Edema

Phase: N/A Priority: Normal
NCT ID: NCT00168337 Org: User:
Start: 05/31/05 End: 05/31/12 Due: 05/31/13

OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder

Phase: N/A Priority: Normal
NCT ID: NCT01945489 Org: User:
Start: 10/28/13 End: 01/05/17 Due: 01/05/18

A Pharmacokinetic Study of MK-1602 in the Treatment of Acute Migraine (MK-1602-007)

Phase: N/A Priority: Normal
NCT ID: NCT01657370 Org: User:
Start: 08/31/12 End: 12/31/12 Due: 12/31/13

A Long-term Follow-up Study of Botulinum Toxin Type A in Patients With Overactive Bladder as a Result of Spinal Injury or Multiple Sclerosis

Phase: N/A Priority: Normal
NCT ID: NCT00876447 Org: User:
Start: 01/01/09 End: 09/04/13 Due: 09/04/14